Ciardullo, C.; Szoltysek, K.; Zhou, P.; Pietrowska, M.; Marczak, L.; Willmore, E.; Enshaei, A.; Walaszczyk, A.; Ho, J.Y.; Rand, V.;
et al. Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia. Cancers 2022, 14, 23.
https://doi.org/10.3390/cancers14010023
AMA Style
Ciardullo C, Szoltysek K, Zhou P, Pietrowska M, Marczak L, Willmore E, Enshaei A, Walaszczyk A, Ho JY, Rand V,
et al. Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia. Cancers. 2022; 14(1):23.
https://doi.org/10.3390/cancers14010023
Chicago/Turabian Style
Ciardullo, Carmela, Katarzyna Szoltysek, Peixun Zhou, Monika Pietrowska, Lukasz Marczak, Elaine Willmore, Amir Enshaei, Anna Walaszczyk, Jia Yee Ho, Vikki Rand,
and et al. 2022. "Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia" Cancers 14, no. 1: 23.
https://doi.org/10.3390/cancers14010023
APA Style
Ciardullo, C., Szoltysek, K., Zhou, P., Pietrowska, M., Marczak, L., Willmore, E., Enshaei, A., Walaszczyk, A., Ho, J. Y., Rand, V., Marshall, S., Hall, A. G., Harrison, C. J., Soundararajan, M., & Eswaran, J.
(2022). Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia. Cancers, 14(1), 23.
https://doi.org/10.3390/cancers14010023